13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q4 2020. See the latest, Q3 2026 →
Reported value
$17.95B
+16% on the quarter before
Positions
1,428
175 new · 108 sold out
Top 10
26.5%
of the value
Est. gain
+$1.26B
on stocks held all quarter
Est. return
+8.9%
on those stocks since Q3 2020
Positions as of Dec 31, 2020, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.
Largest buys
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr Barclays 7 10 Yr~$230.5MAdded · 1.7% → 2.7%+1,921,614 shares
- Proshares Tr Pshs Ult S&P 500~$179.4MAdded · 0.0% → 1.0%+1,964,032 shares
- Ishares Tr Us Treas Bd ETF~$102.0MAdded · 1.1% → 1.5%+3,744,442 shares
- Ishares Tr Iboxx Hi Yd ETF~$89.9MAdded · 1.5% → 1.8%+1,029,655 shares
- Vanguard Index Fds S&P 500 ETF Shs~$82.5MAdded · 5.0% → 5.3%+239,948 shares
- Ishares Tr Ishs 1-5yr Invs~$66.7MAdded · 1.3% → 1.5%+1,209,421 shares
- Ishares Tr Jpmorgan Usd Emg~$64.4MAdded · 0.4% → 0.7%+555,651 shares
- Ishares Tr Rus 1000 Grw ETF~$62.2MAdded · 0.0% → 0.3%+257,924 shares
- Ishares Tr Agency Bond ETF~$61.6MAdded · 0.1% → 0.4%+515,102 shares
- Ishares Tr U.S. Med Dvc ETF~$60.3MAdded · 0.4% → 0.8%+184,298 shares
Largest sells
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR Ser Tr SPDR Bloomberg~$196.8MCut · 1.3% → 0.0%−2,150,698 shares
- SPDR Ser Tr Blomberg Brc Inv~$100.5MCut · 0.7% → 0.0%−3,286,172 shares
- Vanguard Scottsdale Fds Shrt Trm Corp Bd~$90.1MCut · 0.8% → 0.2%−1,082,846 shares
- Ishares Tr 1 3 Yr Treas Bd~$79.7MCut · 1.6% → 0.9%−923,012 shares
- Pimco ETF Tr Enhan Shrt Ma Ac~$76.8MCut · 1.3% → 0.7%−752,947 shares
- SPDR Index Shs Fds Portfolio Devlpd~$61.7MCut · 0.9% → 0.6%−1,827,234 shares
- Ishares Inc Msci Bric Indx~$59.9MCut · 0.3% → 0.0%−1,137,580 shares
- Ishares Tr Fltg Rate Nt ETF~$55.0MCut · 0.4% → 0.0%−1,079,963 shares
- Ishares Tr Usd Inv Grde ETF~$48.9MCut · 0.9% → 0.5%−789,586 shares
- Ishares Tr 10-20 Yr Trs ETF~$46.9MCut · 1.1% → 0.7%−294,833 shares
Holdings
As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Index Fds S&P 500 ETF ShsETF · shares +9.5% · price +11.7% | 5.3% | $946.9M | +$90.7M | ||||||||
| Vanguard World Fd Mega Grwth IndETF · shares +7.1% · price +9.9% | 4.1% | $742.5M | +$62.4M | ||||||||
| Vanguard World Fd Mega Cap Val ETFETF · shares +10% · price +13.2% | 3.2% | $581.4M | +$61.5M | ||||||||
| Ishares Tr Barclays 7 10 YrETF · shares +88% · price −1.5% | 2.7% | $493.2M | −$4.1M | ||||||||
| Ishares Tr Core Msci EafeETF · shares +5.0% · price +14.6% | 2.2% | $399.5M | +$48.5M | ||||||||
| Ishares Inc Core Msci EmktETF · shares +3.9% · price +17.5% | 1.8% | $331.7M | +$47.6M | ||||||||
| Ishares Tr Iboxx Hi Yd ETFETF · shares +38% · price +4.1% | 1.8% | $327.6M | +$9.3M | ||||||||
| Ishares Tr Iboxx Inv Cp ETFETF · shares −4.7% · price +2.5% | 1.8% | $323.0M | +$8.0M | ||||||||
| Vanguard Index Fds Sm Cp Val ETFETF · shares +8.4% · price +28.5% | 1.7% | $307.5M | +$63.0M | ||||||||
| SPDR Ser Tr Bloomberg BrclysETF · shares −4.7% · price +4.5% | 1.6% | $294.1M | +$12.6M | ||||||||
| Ishares Tr Ishs 1-5yr InvsETF · shares +32% · price +0.5% | 1.5% | $273.1M | +$973,177 | ||||||||
| SPDR Ser Tr Portfolio S&P500ETF · shares −9.2% · price +11.7% | 1.5% | $272.3M | +$28.6M | ||||||||
| Ishares Tr Us Treas Bd ETFETF · shares +60% · price −2.5% | 1.5% | $271.2M | −$4.4M | ||||||||
| Vanguard Scottsdale Fds Mortg-Back SecETF · shares +4.1% · price −0.4% | 1.3% | $235.7M | −$837,958 | ||||||||
| Vanguard Index Fds Value ETFETF · shares −0.3% · price +13.8% | 1.2% | $220.5M | +$26.8M | ||||||||
| Vanguard Charlotte Fds Intl Bd Idx ETFETF · shares +18% · price +0.6% | 1.2% | $220.2M | +$1.2M | ||||||||
| Ishares Tr Mbs ETFETF · shares +21% · price −0.2% | 1.2% | $218.6M | −$443,161 | ||||||||
| Vanguard Index Fds Sml Cp Grw ETFETF · shares +0.4% · price +24.5% | 1.2% | $209.7M | +$41.2M | ||||||||
| Select Sector SPDR Tr TechnologyETF · shares +13% · price +11.4% | 1.2% | $207.0M | +$18.8M | ||||||||
| Vanguard Index Fds Mcap Gr IdxvipETF · shares +7.9% · price +17.7% | 1.1% | $204.1M | +$28.5M | ||||||||
| AppleCOM · shares +1.2% · price +14.6% | 1.1% | $199.7M | +$25.1M | ||||||||
| Vanguard Index Fds Extend Mkt ETFETF · shares +3.6% · price +27.0% | 1.1% | $199.2M | +$40.8M | ||||||||
| Ishares Tr 0-5yr Hi Yl CpETF · shares +12% · price +3.4% | 1.1% | $196.3M | +$5.7M | ||||||||
| Vanguard Index Fds Mcap Vl IdxvipETF · shares +17% · price +17.4% | 1.0% | $187.7M | +$23.7M | ||||||||
| Proshares Tr Pshs Ult S&P 500ETF · shares +391,241% · price +23.9% | 1.00% | $179.5M | +$8,858 | ||||||||
| Total · 1,428 positions | 100% | $17.95B | +$1.26B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2020 to Q4 2020: 1,206 stocks held throughout, up $1.26B (+8.9%).
- Vanguard Index Fds S&P 500 ETF Shs+$90.7M+12%
- Vanguard Index Fds Sm Cp Val ETF+$63.0M+29%
- Vanguard World Fd Mega Grwth Ind+$62.4M+10%
- Vanguard World Fd Mega Cap Val ETF+$61.5M+13%
- Ishares Tr Core Msci Eafe+$48.5M+15%
- Ishares Tr Us Treas Bd ETF−$4.4M−3%
- Newmont Corp Com−$4.5M−6%
- Ishares Tr 10-20 Yr Trs ETF−$5.6M−4%
- Amgen Inc Com−$8.1M−10%
- Biogen Inc Com−$8.9M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 10 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |